semaglutide
6 Semaglutide vs Tirzepatide vs Retatrutide Wins - MC4R Insights
For patients with MC4R-deficient obesity, tirzepatide currently shows the greatest average weight loss, though individual response varies by genotype and tolerability. In a 2024 UK trial, semaglutide 7.2 mg trimmed body weight by 13% in MC4R-deficient participants, while tirzepatide hit 18.4% and retatrutide settled at 16.5% after